Inclisiran effectively and safely lowered LDL in patients with hyperlipidemia and prior cerebrovascular disease, according to a pooled analysis of the three ORION trials presented at the National Lipid Association Scientific Sessions.
“Patients with hyperlipidemia and established cerebrovascular disease are at an increased risk of future strokes or other cardiovascular events. In ischemic stroke survivors, treatment with statins and inhibitors of PCSK9 reduce recurrent cardiovascular events including stroke,” R. Scott Wright, MD, consultant in the divisions of structural heart